is there a patent on semaglutide expires next year: Novo Nordisk faces tough competition in the Chinese obesity market Semaglutide patent expiry in India

Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987

In recent years, its been FDA-approved for chronic weight management under brand names like Wegovy and Ozempic

Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications Brooke McCormick Rose McNulty Key Takeaways Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications

Alternative diabetes treatments should be considered in consultation with your healthcare team